Spinal Tech Archives - Page 687 of 1229

Brian Ennis becomes president of Implanet America: 5 key notes

Implanet hired Brian T. Ennis as president of Implanet America.

Dr. David Greenwald 1st to successfully implant VerteLP Lateral Lumber Cage: 4 key notes

David Greenwald, MD, successfully implanted the 1st patent-pending VerteLP Lateral Lumber Cage from VGI Medical.

Orthopedic, spine device company M&A & partnerships: 9 recent deals

Here are nine recent mergers, acquisitions and partnership agreements that took place among spine and orthopedic companies.

Stryker director sells 12k shares, soon after Sage Products acquisition & potential Moody's downgrade: 7 points

Ronda E. Stryker, director at Stryker, sold 12,000 shares of the company's stock in a recent transaction, according to a Daily Political report.

OsteoCool RF Ablation System reduces pain for metastatic spinal tumor treatment: 4 things to know

Medtronic's OsteoCool RF Ablation System is designed to decrease pain associated with metastatic spinal tumor treatment, according to HospiMedica.com.

Declining prices cause financial issues for medical device companies: 5 insights

Various trends are pushing down medical device prices and forcing technology companies to alter their business strategies, according to StarTribune.

Cervical total disc replacement device market to grow at CAGR of 23% — 4 notes

The cervical total disc replacement device market reached $489.7 million in 2015, based on a Persistence report, according to medGadget.

Smith & Nephew insider sells 11k+ shares: 4 facts

Smith & Nephew insider Julie Brown sold 11,789 shares of the company's stock, according to Daily Political.

Zimmer Biomet investors to offer 11M+ shares of common stock: 5 takeaways

Some of Zimmer Biomet's shareholders affiliated with Blackstone and Goldman Zachs plan to offer more than 11 million common stock shares for sale, according to The Journal Gazette.

FDA schedules meeting to review Cartiva's PMA for synthetic cartilage implant: 4 points

The FDA has tentatively scheduled a meeting of the Orthopaedic and Rehabilitation Devices Panel to review Cartiva's premarket approval application for its Cartiva Synthetic Cartilage Implant.